MED eps in a glimpse
Analyst Rating Consensus
29
Ratings
MED Price Target
Highest Price Target
$265.00
NaN% Upside
)Mean Price Target
$91.99
365.99% Upside
)Lowest Price Target
$17.50
-11.35% Downside
)MED Price Target History
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
MED Earnings History
Frequently Asked Questions
Brokerage firms have given MED stock an average recommendation of Hold. 29 analysts have given their ratings to MED out of which 8 analysts have given strong buy call, 8 analysts have given buy call, 12 analysts rate it hold, 1 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $91.99 gives the stock implied upside of roughly 365.99% over the next year or so.
Analysts suggest MED's stock price would rise to a high of $265.00.
Within the next 12 months, analysts predict the MED stock price could move to $17.50.
MED stock has an average analyst estimate of $91.99.
MED shares are currently trading 365.99% above this price target.
Its quarterly earnings per share (EPS) came in at $0.10 versus consensus estimates of -$0.28, and below the comparable year-ago quarter’s EPS of $2.12.
MED's forecasts by analysts estimating quarterly EPS at -$0.16 and -$43.21 for the whole year.
The analysts have projected 20% EPS growth for MED in the next five years, compared to growth rates of 14.53% in the past five years.